{"recordsFiltered":49262,"recordsTotal":49262,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=days_late&start=42300","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=days_late&start=41700","results":[{"registry_id":"NCT07419373","publication_url":"https://clinicaltrials.gov/study/NCT07419373","title":"A Phase 2 Study to Evaluate Safety, Tolerability, And Virologic Efficacy of ARN-75039 For the Treatment of Lassa Fever in West Africa","has_exemption":false,"start_date":"2026-02-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Arisan Therapeutics, Inc.","sponsor_slug":"arisan-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07425015","publication_url":"https://clinicaltrials.gov/study/NCT07425015","title":"Ambulatory Long Length URodynamics Evaluation","has_exemption":false,"start_date":"2026-02-17","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Bright Uro","sponsor_slug":"bright-uro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07368959","publication_url":"https://clinicaltrials.gov/study/NCT07368959","title":"ASTRA: A Phase 3 Multi-center, Randomized, Double-Masked, Prospective Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-3)","has_exemption":false,"start_date":"2026-02-19","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Aurion Biotech","sponsor_slug":"aurion-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293715","publication_url":"https://clinicaltrials.gov/study/NCT07293715","title":"Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)","has_exemption":false,"start_date":"2026-02-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07328542","publication_url":"https://clinicaltrials.gov/study/NCT07328542","title":"A Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of Testosterone Cypionate Injection in Hypogonadal Men","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Azurity Pharmaceuticals","sponsor_slug":"azurity-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07441395","publication_url":"https://clinicaltrials.gov/study/NCT07441395","title":"A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Moderate to Severe Atopic Dermatitis (SIERRA1)","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Corvus Pharmaceuticals, Inc.","sponsor_slug":"corvus-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277582","publication_url":"https://clinicaltrials.gov/study/NCT07277582","title":"A Phase 2/3, Two-part, Dose-ranging, Adaptive Study to Evaluate Efficacy and Safety of THRV-1268 in Participants Diagnosed With Long QT Syndrome Type 2 (LQTS 2)","has_exemption":false,"start_date":"2026-03-07","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Thryv Therapeutics, Inc.","sponsor_slug":"thryv-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07306182","publication_url":"https://clinicaltrials.gov/study/NCT07306182","title":"A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of SGC001 Injection in Chinese Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction and Planned for Primary Percutaneous Coronary Intervention (pPCI)","has_exemption":false,"start_date":"2026-03-09","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Beijing Sungen Biomedical Technology Co., Ltd","sponsor_slug":"beijing-sungen-biomedical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07048314","publication_url":"https://clinicaltrials.gov/study/NCT07048314","title":"A Randomized Clinical Trial to Assess Safety and Efficacy of Allogeneic Adipose-derived Mesenchymal Stem Cells in Promoting the Recovery of Erectile Function Post Radical Retropubic Prostatectomy of Localized Prostate Cancer","has_exemption":false,"start_date":"2026-03-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660186","publication_url":"https://clinicaltrials.gov/study/NCT06660186","title":"Randomized Trial of Rigid Plate Fixation Versus Wire Cerclage in High-Risk Sternotomy Patients","has_exemption":false,"start_date":"2026-03-12","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07363577","publication_url":"https://clinicaltrials.gov/study/NCT07363577","title":"A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Efficacy and Safety of LB 102 in the Treatment of Adult Patients With Acute Schizophrenia","has_exemption":false,"start_date":"2026-03-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"LB Pharmaceuticals Inc.","sponsor_slug":"lb-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513142","publication_url":"https://clinicaltrials.gov/study/NCT07513142","title":"A Single Blind, Randomized Controlled Trial Evaluating Platelet Poor Plasma Versus Corticosteroid Injections as A Control for Thigh Muscle Injuries","has_exemption":false,"start_date":"2026-03-25","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Andrews Research & Education Foundation","sponsor_slug":"andrews-research-education-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07502495","publication_url":"https://clinicaltrials.gov/study/NCT07502495","title":"A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets Despite Antihyperglycemic Medications","has_exemption":false,"start_date":"2026-03-27","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Biomea Fusion Inc.","sponsor_slug":"biomea-fusion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07159373","publication_url":"https://clinicaltrials.gov/study/NCT07159373","title":"Safety and Efficacy Trial of Mass Drug Administration With Moxidectin Versus Ivermectin in Combination With Diethylcarbamazine and Albendazole for Lymphatic Filariasis, Scabies, and Strongyloidiasis in Fiji","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Medicines Development for Global Health","sponsor_slug":"medicines-development-for-global-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184385","publication_url":"https://clinicaltrials.gov/study/NCT07184385","title":"A Multicenter, Double-blind, Randomized, Placebo-controlled, Two-arm Phase III Study to Assess the Efficacy of Human Umbilical Cord Blood (REGENECYTE) Infusion in Reducing Fatigue in Post-COVID Condition","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"StemCyte, Inc.","sponsor_slug":"stemcyte-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07485478","publication_url":"https://clinicaltrials.gov/study/NCT07485478","title":"Effects of the Invisalign® Palatal Expander (IPE) vs. Rapid Palatal Expander With Facemask in Growing Skeletal Class III Patients: A CBCT Randomized Clinical Trial","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Mahidol University","sponsor_slug":"mahidol-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07236190","publication_url":"https://clinicaltrials.gov/study/NCT07236190","title":"Early-phase Biomarker-based Trial of NPC-1 for Alzheimer's Disease Pathology","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07481370","publication_url":"https://clinicaltrials.gov/study/NCT07481370","title":"A Prospective Comparison of Isotretinoin and hCG Therapy in Males With Oligospermia and Azoospermia","has_exemption":false,"start_date":"2026-04-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07533006","publication_url":"https://clinicaltrials.gov/study/NCT07533006","title":"A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Proof of Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Severe Alopecia Areata","has_exemption":false,"start_date":"2026-04-14","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07081997","publication_url":"https://clinicaltrials.gov/study/NCT07081997","title":"A Phase 3, Multicenter, Randomized, Open-Label Trial Investigating the Safety, Tolerability and Efficacy of Palopegteriparatide Administered Subcutaneously Daily at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism","has_exemption":false,"start_date":"2026-04-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Ascendis Pharma Bone Diseases A/S","sponsor_slug":"ascendis-pharma-bone-diseases-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06200961","publication_url":"https://clinicaltrials.gov/study/NCT06200961","title":"Use of Sedation-Free Transnasal Endoscopy to Improve Access and Lower Costs of Endoscopic Evaluations in a Bariatric Medical and Surgical Program","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Christopher C. Thompson, MD, MSc","sponsor_slug":"christopher-c-thompson-md-msc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07268118","publication_url":"https://clinicaltrials.gov/study/NCT07268118","title":"Randomized Control Trial for Pain Control With Topical Lidocaine for Cervical Ripening Balloon Placement","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447934","publication_url":"https://clinicaltrials.gov/study/NCT07447934","title":"Vibrotactile Stimulation for Lower Limb Spasticity","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07502508","publication_url":"https://clinicaltrials.gov/study/NCT07502508","title":"Phase 2 Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Not Achieving Glycemic Targets Despite GLP-1-Based Therapy","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Biomea Fusion Inc.","sponsor_slug":"biomea-fusion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07543367","publication_url":"https://clinicaltrials.gov/study/NCT07543367","title":"INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Synchron, Inc.","sponsor_slug":"synchron-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07559175","publication_url":"https://clinicaltrials.gov/study/NCT07559175","title":"A Phase 2a, Randomized, Open-Label, Active-Controlled, Crossover Study to Evaluate Safety and Explore Efficacy of Different Doses of New Lipase NHS7108 Administered Orally in Participants With Exocrine Pancreatic Insufficiency- EPIC","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Aimmune Nestlé Health Science US R&D, LLC","sponsor_slug":"aimmune-nestle-health-science-us-rd-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07483099","publication_url":"https://clinicaltrials.gov/study/NCT07483099","title":"A Phase 2, Multicenter, Randomized, Open-Label, Active-Controlled Study to Investigate LY4395089/Mirikizumab Co-administration Compared With Mirikizumab in Adults With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2026-05-04","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07483073","publication_url":"https://clinicaltrials.gov/study/NCT07483073","title":"A Master Protocol for Phase 2, Randomized, Controlled Studies of Multiple Interventions for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease","has_exemption":false,"start_date":"2026-05-04","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07612644","publication_url":"https://clinicaltrials.gov/study/NCT07612644","title":"Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)","has_exemption":false,"start_date":"2026-05-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07615010","publication_url":"https://clinicaltrials.gov/study/NCT07615010","title":"Phase 2 Adaptive Randomized, Placebo -Controlled Trial of agenT-797 + Standard of Care Vs. Placebo + Standard of Care in Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure (AHRF) By Global ARDS Criteria","has_exemption":false,"start_date":"2026-05-22","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"MiNK Therapeutics","sponsor_slug":"mink-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523581","publication_url":"https://clinicaltrials.gov/study/NCT07523581","title":"A Randomized, Double-Blind, Placebo-Controlled, Delayed-Start Study to Evaluate the Efficacy and Safety of Exaluren in Alport Syndrome Patients With Nonsense Mutations in COL4A3/4/5 Genes","has_exemption":false,"start_date":"2026-05-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Eloxx Pharmaceuticals, Inc.","sponsor_slug":"eloxx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05326165","publication_url":"https://clinicaltrials.gov/study/NCT05326165","title":"Preventing the Progression of Low Volume Swelling to Breast Cancer-related Lymphedema: a Pilot Study","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07348601","publication_url":"https://clinicaltrials.gov/study/NCT07348601","title":"A Proof-of-Concept Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of CSTI-500 in Participants With Prader-Willi Syndrome","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"ConSynance Therapeutics","sponsor_slug":"consynance-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447206","publication_url":"https://clinicaltrials.gov/study/NCT07447206","title":"Vascular Intervention Strategies Trial for Alzheimer's (VISTA)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07536022","publication_url":"https://clinicaltrials.gov/study/NCT07536022","title":"Developing At-home taVNS for Neurorehabilitation in Parkinson's Disease","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07460947","publication_url":"https://clinicaltrials.gov/study/NCT07460947","title":"A Pilot Trial of One Day Accelerated Intermittent Theta-burst Stimulation Plus D-cycloserine in Suicidal Patients With Borderline Personality Disorder (ONE-D BPD)","has_exemption":false,"start_date":"2026-06-09","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07336368","publication_url":"https://clinicaltrials.gov/study/NCT07336368","title":"Topical Cryotherapy to Reduce Pain During Steroid Injections for Keloid and Hypertrophic Scars: A Pilot Study","has_exemption":false,"start_date":"2026-06-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Sonal Choudhary","sponsor_slug":"sonal-choudhary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07625332","publication_url":"https://clinicaltrials.gov/study/NCT07625332","title":"Pilot Study of Tolerability and Preliminary Efficacy of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)","has_exemption":false,"start_date":"2026-06-15","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05470478","publication_url":"https://clinicaltrials.gov/study/NCT05470478","title":"Enhancement and Optimization of a Mobile iBCI for Veterans With Paralysis","has_exemption":false,"start_date":"2026-06-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07644559","publication_url":"https://clinicaltrials.gov/study/NCT07644559","title":"A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and With Cetuximab, in Patients With Metastatic KRAS G12D-Mutated Pancreatic Cancer (TARGET-D 201)","has_exemption":false,"start_date":"2026-06-16","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Verastem, Inc.","sponsor_slug":"verastem-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05054790","publication_url":"https://clinicaltrials.gov/study/NCT05054790","title":"A Phase 2 Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct In Subjects With Fibrotic Contracted Bladder","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05279937","publication_url":"https://clinicaltrials.gov/study/NCT05279937","title":"The Use of Ultrasound-Guided Dextrose Prolotherapy in Low Back Pain in Patients With Hypermobile-Type, Ehlers-Danlos Syndrome","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Tulane University","sponsor_slug":"tulane-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660017","publication_url":"https://clinicaltrials.gov/study/NCT06660017","title":"Ketamine Oral Rinse in the Management of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518941","publication_url":"https://clinicaltrials.gov/study/NCT06518941","title":"An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06880562","publication_url":"https://clinicaltrials.gov/study/NCT06880562","title":"Renal and Splanchnic Sympathetic Denervation as an Alternative Therapy for Resistant Hypertension and Type 2 Diabetes (RESPLASH Study)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Tulane University","sponsor_slug":"tulane-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06884176","publication_url":"https://clinicaltrials.gov/study/NCT06884176","title":"Complication Rates Associated With Central Venous Catheters Versus Midline Catheters: A Randomized Control Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959082","publication_url":"https://clinicaltrials.gov/study/NCT06959082","title":"A Multi-center, Randomized, Open-label, Parallel-group, Phase 2 Study to Evaluate the Efficacy and Safety of VS-101 in Combination With Chemoradiotherapy (CRT) in Patients With Head and Neck Cancer","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"VSPharmTech Co.,Ltd.","sponsor_slug":"vspharmtech-coltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06963216","publication_url":"https://clinicaltrials.gov/study/NCT06963216","title":"A Phase III Open-Label Multi-Center Study of the Pharmacokinetics, Safety, and Efficacy of Coagadex in the Treatment of Adults With Acquired Factor X Deficiency Associated With Light Chain Amyloidosis","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Kedrion S.p.A.","sponsor_slug":"kedrion-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06966492","publication_url":"https://clinicaltrials.gov/study/NCT06966492","title":"Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07038889","publication_url":"https://clinicaltrials.gov/study/NCT07038889","title":"Investigating the Feasibility and Translational Therapeutic Benefits of Overground, Fully Immersive Virtual Reality (VR) Gait Rehabilitation Therapies for Individuals With Traumatic Brain Injury (TBI)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215481","publication_url":"https://clinicaltrials.gov/study/NCT07215481","title":"Quantitative Digitography to Evaluate the Efficacy of Image Guided Algorithmic DBS Programming","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07185945","publication_url":"https://clinicaltrials.gov/study/NCT07185945","title":"Phase II Trial of Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Guru Sonpavde","sponsor_slug":"guru-sonpavde","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321860","publication_url":"https://clinicaltrials.gov/study/NCT07321860","title":"Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Partial TGF-βR1 (ALK5) Inhibition With Galunisertib Combined With PDE4 Inhibition With Nerandomilast in GREM2-Positive ALS","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Gipfel Life Sciences GmbH","sponsor_slug":"gipfel-life-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424183","publication_url":"https://clinicaltrials.gov/study/NCT07424183","title":"T4/T3 Therapy in Hypothyroidism","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07461506","publication_url":"https://clinicaltrials.gov/study/NCT07461506","title":"Mitigating Opioid Use Disorder Risk With Enhanced Opioid Sparing Pain Relief for Wisdom Teeth Extractions With a Novel Nanotechnology","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"nCap Medical","sponsor_slug":"ncap-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07473128","publication_url":"https://clinicaltrials.gov/study/NCT07473128","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre Trial Comparing Efficacy and Safety of Trilaciclib Versus Placebo in Participants With Limited-stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Pharmacosmos A/S","sponsor_slug":"pharmacosmos-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07475091","publication_url":"https://clinicaltrials.gov/study/NCT07475091","title":"Pharyngeal High Resolution Manometry Standardization of Metrics","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07478055","publication_url":"https://clinicaltrials.gov/study/NCT07478055","title":"Biomarkers in Management of PP Preeclampsia","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Alexander Harrison","sponsor_slug":"alexander-harrison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07494838","publication_url":"https://clinicaltrials.gov/study/NCT07494838","title":"IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Lucas R. Cusumano, MD","sponsor_slug":"lucas-r-cusumano-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07518901","publication_url":"https://clinicaltrials.gov/study/NCT07518901","title":"Ferumoxytol Nanozymes for Biofilm Disruption: A Clinical Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07540897","publication_url":"https://clinicaltrials.gov/study/NCT07540897","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 Study 304)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Alkermes, Inc.","sponsor_slug":"alkermes-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07572591","publication_url":"https://clinicaltrials.gov/study/NCT07572591","title":"Assessment of Wearable Ultrasound for Modulation","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07575308","publication_url":"https://clinicaltrials.gov/study/NCT07575308","title":"HMBeacon: A Phase 2, Randomized, Double-blind Study of the Safety, Tolerability, Efficacy, and Pharmacodynamics of Multiple Dose ALN-6400 in Adult and Adolescent Female Patients With Von Willebrand Disease (VWD) and Heavy Menstrual Bleeding (HMB)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07582211","publication_url":"https://clinicaltrials.gov/study/NCT07582211","title":"Bilevel Positive Airway Pressure (BPAP) for Severe Asthma Exacerbations: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07580404","publication_url":"https://clinicaltrials.gov/study/NCT07580404","title":"The Utility of Emsella for Reducing Transient Stress Urinary Incontinence (tSUI) Following Holmium Laser Enucleation of the Prostate (HoLEP)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07590518","publication_url":"https://clinicaltrials.gov/study/NCT07590518","title":"AI-Enhanced Virtual Reality Cognitive Behavioral Therapy to Reduce Anxiety and Improve Quality of Life in Patients With Inflammatory Bowel Disease: A Multicenter Pilot and Feasibility Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Brennan Spiegel","sponsor_slug":"brennan-spiegel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07599826","publication_url":"https://clinicaltrials.gov/study/NCT07599826","title":"Active vs. Passive Virtual Reality for Reducing Pain and Anxiety During Office-based ENT Procedures","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07610746","publication_url":"https://clinicaltrials.gov/study/NCT07610746","title":"Early Detection of Neonatal Opioid Withdrawal Syndrome Using a Novel Cerebral Monitor.","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07613658","publication_url":"https://clinicaltrials.gov/study/NCT07613658","title":"3D-Printed Custom Versus Conventional Band-and-Loop Versus Chairside Denovo Space Maintainers in the Primary Dentition: A Randomized Controlled Trial Protocol","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Murad Alrashidi","sponsor_slug":"murad-alrashidi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07625293","publication_url":"https://clinicaltrials.gov/study/NCT07625293","title":"A Phase 2a Study of DB-3Q for the Treatment of Medically Refractory Crohn's Disease","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Direct Biologics, LLC","sponsor_slug":"direct-biologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07632742","publication_url":"https://clinicaltrials.gov/study/NCT07632742","title":"MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07659795","publication_url":"https://clinicaltrials.gov/study/NCT07659795","title":"A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, With and Without an Anti-EGFR Antibody, and With an Anti-EGFR Antibody and Chemotherapy, in Patients With Metastatic KRAS G12D-Mutated Colorectal Adenocarcinoma (TARGET-D 203)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Verastem, Inc.","sponsor_slug":"verastem-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07659782","publication_url":"https://clinicaltrials.gov/study/NCT07659782","title":"A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients With Previously Treated, Advanced KRAS G12D-Mutated Non-Small Cell Lung Cancer (TARGET-D 202)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Verastem, Inc.","sponsor_slug":"verastem-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06327373","publication_url":"https://clinicaltrials.gov/study/NCT06327373","title":"A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06818981","publication_url":"https://clinicaltrials.gov/study/NCT06818981","title":"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Post-Operative Steroids After Sleep Surgery","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07339215","publication_url":"https://clinicaltrials.gov/study/NCT07339215","title":"A Prospective Randomized Trial of Local Antibiotic Carriers in Tissue Expander-Based Breast Reconstruction","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07557121","publication_url":"https://clinicaltrials.gov/study/NCT07557121","title":"A Phase 2, Multicenter, Randomized, Active-controlled Trial of the Safety and Efficacy of AIV007 by Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Aiviva BioPharma Inc.","sponsor_slug":"aiviva-biopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05643144","publication_url":"https://clinicaltrials.gov/study/NCT05643144","title":"Enhancing Shared Decision-making to Prompt and Guide Individualized Care for People With Alzheimer's Disease and Diabetes","has_exemption":false,"start_date":"2026-07-10","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06557733","publication_url":"https://clinicaltrials.gov/study/NCT06557733","title":"Phase 2 Study to Evaluate the Efficacy and Safety of TPST-1495 in Patients With Familial Adenomatous Polyposis (FAP)","has_exemption":false,"start_date":"2026-07-13","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07595302","publication_url":"https://clinicaltrials.gov/study/NCT07595302","title":"Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain: A Randomized, Double-Blind, Double-Dummy Controlled Trial (PIVOTAL Trial)","has_exemption":false,"start_date":"2026-07-30","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06806332","publication_url":"https://clinicaltrials.gov/study/NCT06806332","title":"Glaucoma Drop Aids Part 2","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Boston Medical Center","sponsor_slug":"boston-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07411378","publication_url":"https://clinicaltrials.gov/study/NCT07411378","title":"A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of 20-hydroxyecdysone (20E) in Reducing the Muscle Strength Loss From the GLP1 Agonist Semaglutide in Combination With Dieting in Obese and Overweight Adult Patients (OBA).","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Biophytis","sponsor_slug":"biophytis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07544667","publication_url":"https://clinicaltrials.gov/study/NCT07544667","title":"Intravaginal Injection of Poly-L-Lactic Acid for Treatment of Cystocele: A Randomized Trial","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Cassandra Kisby","sponsor_slug":"cassandra-kisby","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07557862","publication_url":"https://clinicaltrials.gov/study/NCT07557862","title":"Multi-Site Randomized Controlled Trial of STARgraft (10401) Vascular Graft for Hemodialysis Access","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Healionics Corporation","sponsor_slug":"healionics-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07619300","publication_url":"https://clinicaltrials.gov/study/NCT07619300","title":"Pilot Study: Dorsal Root Ganglion Stimulation After Spinal Cord Injury-Related Lower Motor Neuron Damage","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Peter J. Grahn, Ph.D.","sponsor_slug":"peter-j-grahn-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07171359","publication_url":"https://clinicaltrials.gov/study/NCT07171359","title":"Transcranial Magnetic Stimulation (TMS) to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)","has_exemption":false,"start_date":"2027-06-01","completion_date":"2027-06-30","has_results":false,"results_due":false,"sponsor_name":"Washington State University","sponsor_slug":"washington-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02756897","publication_url":"https://clinicaltrials.gov/study/NCT02756897","title":"A Phase II Study of Venetoclax and Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL)","has_exemption":false,"start_date":"2016-07-07","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03964090","publication_url":"https://clinicaltrials.gov/study/NCT03964090","title":"A Study of Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)","has_exemption":false,"start_date":"2019-06-27","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04033497","publication_url":"https://clinicaltrials.gov/study/NCT04033497","title":"Treatment Response Assessment Maps (TRAMs) in the Delineation of Radiation Necrosis From Tumor Progression After Stereotactic Radiation in Patients With Brain Metastases: A Prospective Study","has_exemption":false,"start_date":"2019-08-20","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04068194","publication_url":"https://clinicaltrials.gov/study/NCT04068194","title":"A Phase I/II Study of M3814 and Avelumab in Combination With Hypofractionated Radiation in Patients With Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies","has_exemption":false,"start_date":"2020-04-07","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04322318","publication_url":"https://clinicaltrials.gov/study/NCT04322318","title":"Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)","has_exemption":false,"start_date":"2020-10-19","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04696575","publication_url":"https://clinicaltrials.gov/study/NCT04696575","title":"A Phase II Trial of Lamivudine in Combination With Chemoimmunotherapy in Patients With Extensive Stage SCLC","has_exemption":false,"start_date":"2021-07-02","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03597594","publication_url":"https://clinicaltrials.gov/study/NCT03597594","title":"Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)","has_exemption":false,"start_date":"2021-09-02","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05026749","publication_url":"https://clinicaltrials.gov/study/NCT05026749","title":"Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children","has_exemption":false,"start_date":"2022-02-27","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04086485","publication_url":"https://clinicaltrials.gov/study/NCT04086485","title":"Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)","has_exemption":false,"start_date":"2022-10-03","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05641753","publication_url":"https://clinicaltrials.gov/study/NCT05641753","title":"CHORD1 - CHOlesterol Lowering and Residual Risk in Diabetes, Type 1","has_exemption":false,"start_date":"2022-12-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05442515","publication_url":"https://clinicaltrials.gov/study/NCT05442515","title":"Phase 1/2 Dose Escalation Study of CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies","has_exemption":false,"start_date":"2022-12-28","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04665739","publication_url":"https://clinicaltrials.gov/study/NCT04665739","title":"Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors","has_exemption":false,"start_date":"2023-02-03","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05411081","publication_url":"https://clinicaltrials.gov/study/NCT05411081","title":"A Phase II Randomized Trial of Cabozantinib (NSC #761968) With or Without Atezolizumab (NSC #783608) in Patients With Advanced Papillary Renal Cell Carcinoma (PAPMET2)","has_exemption":false,"start_date":"2023-03-24","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05610085","publication_url":"https://clinicaltrials.gov/study/NCT05610085","title":"A Phase IIb Dose Escalation Study of Levetiracetam for the Treatment of Neonatal Seizures","has_exemption":false,"start_date":"2023-03-24","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05570825","publication_url":"https://clinicaltrials.gov/study/NCT05570825","title":"A Phase 2 Trial of SX-682 and Pembrolizumab in Patients With Treatment Naive Stage IV or Recurrent Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2023-04-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05419011","publication_url":"https://clinicaltrials.gov/study/NCT05419011","title":"A Phase IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccines (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome","has_exemption":false,"start_date":"2023-05-08","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05724563","publication_url":"https://clinicaltrials.gov/study/NCT05724563","title":"Phase II Basket Trial of Domvanalimab (AB154) and Zimberelimab (AB122) in Advanced Hepatobiliary Cancers","has_exemption":false,"start_date":"2023-06-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05846399","publication_url":"https://clinicaltrials.gov/study/NCT05846399","title":"CAT BITE Antibiotic Prophylaxis and Durations for the Hand/Forearm (CATBITE): A Prospective, Randomized, Placebo-controlled, Double-blinded, Clinical Trial","has_exemption":false,"start_date":"2023-09-07","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05891769","publication_url":"https://clinicaltrials.gov/study/NCT05891769","title":"Evaluation of Patients With Suspected Parathyroid Adenoma and Negative or Equivocal 99mTc Sestamibi SPECT/CT Using 18F Fluorocholine PET/CT","has_exemption":false,"start_date":"2023-09-27","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Andrei Iagaru","sponsor_slug":"andrei-iagaru","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06430931","publication_url":"https://clinicaltrials.gov/study/NCT06430931","title":"Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery: a Multicentre, Phase 11-111, Partially Randomised Patient Preference Trial","has_exemption":false,"start_date":"2023-12-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Meander Medical Center","sponsor_slug":"meander-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05765500","publication_url":"https://clinicaltrials.gov/study/NCT05765500","title":"RecoverPC: A Phase 2 Study of RElugolix Versus GnRH Agonist Quality of Life (QOL) and Testosterone reCOVERy in Men With Prostate Cancer","has_exemption":false,"start_date":"2024-02-12","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06053580","publication_url":"https://clinicaltrials.gov/study/NCT06053580","title":"Repurposing Valsartan May Protect Against Pulmonary Hypertension","has_exemption":false,"start_date":"2024-02-28","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333262","publication_url":"https://clinicaltrials.gov/study/NCT06333262","title":"A Phase 2 Study of Fixed Duration Therapy With Pirtobrutinib and Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia (POP)","has_exemption":false,"start_date":"2024-04-22","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Inhye Ahn","sponsor_slug":"inhye-ahn","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06380517","publication_url":"https://clinicaltrials.gov/study/NCT06380517","title":"A Randomized Trial of Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age","has_exemption":false,"start_date":"2024-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07640425","publication_url":"https://clinicaltrials.gov/study/NCT07640425","title":"A Phase 1/2, Multicenter, Dose Escalating, Dose Expanding, Adaptive Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of Collagenase CNT201 in Adult Participants With Dupuytren's Contracture","has_exemption":false,"start_date":"2024-07-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"CONNEXT","sponsor_slug":"connext","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06261814","publication_url":"https://clinicaltrials.gov/study/NCT06261814","title":"2D and 3D Contrast Enhanced Ultrasound of Chemoembolization","has_exemption":false,"start_date":"2024-08-07","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"john eisenbrey","sponsor_slug":"john-eisenbrey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05947071","publication_url":"https://clinicaltrials.gov/study/NCT05947071","title":"Comparison of High vs Standard Dose Influenza Vaccines in Pediatric Solid Organ Transplant Recipients","has_exemption":false,"start_date":"2024-09-26","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06579703","publication_url":"https://clinicaltrials.gov/study/NCT06579703","title":"Ketorolac Dosing for Acute Vaso-Occlusive Crisis in Pediatric Patients With Sickle Cell Disease","has_exemption":false,"start_date":"2024-09-30","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Children's Blood and Cancer Center at Dell Children's Medical Center","sponsor_slug":"childrens-blood-and-cancer-center-at-dell-childrens-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06444269","publication_url":"https://clinicaltrials.gov/study/NCT06444269","title":"Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial","has_exemption":false,"start_date":"2024-10-11","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06511908","publication_url":"https://clinicaltrials.gov/study/NCT06511908","title":"An Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression","has_exemption":false,"start_date":"2024-11-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Mental Health (NIMH)","sponsor_slug":"national-institute-of-mental-health-nimh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06803888","publication_url":"https://clinicaltrials.gov/study/NCT06803888","title":"Efficacy and Safety of Bariatric Surgery, Semaglutide Once Weekly, and Tirzepatide Once Weekly in Patients With Obesity","has_exemption":false,"start_date":"2025-01-29","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Ali Aminian","sponsor_slug":"ali-aminian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06797219","publication_url":"https://clinicaltrials.gov/study/NCT06797219","title":"Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4","has_exemption":false,"start_date":"2025-02-25","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518057","publication_url":"https://clinicaltrials.gov/study/NCT06518057","title":"A Multi-Center Phase 2 Study of Hippocampal Avoidance in Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumors","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06598423","publication_url":"https://clinicaltrials.gov/study/NCT06598423","title":"Pilot Test of a Novel Wavelength-Based Method to Control Childhood Myopia","has_exemption":false,"start_date":"2025-04-10","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06754501","publication_url":"https://clinicaltrials.gov/study/NCT06754501","title":"A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary","has_exemption":false,"start_date":"2025-04-11","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06907446","publication_url":"https://clinicaltrials.gov/study/NCT06907446","title":"Comparison of BARD Max Core 18g Needle With Uro1 SUREcore 18g Needle in Targeted Prostate Biopsies","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07065669","publication_url":"https://clinicaltrials.gov/study/NCT07065669","title":"Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2025-06-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06610448","publication_url":"https://clinicaltrials.gov/study/NCT06610448","title":"Wearable Evaluation of Ambulatory Readings for Blood Pressure","has_exemption":false,"start_date":"2025-06-06","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Stephen Juraschek","sponsor_slug":"stephen-juraschek","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104500","publication_url":"https://clinicaltrials.gov/study/NCT07104500","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants Without Type 2 Diabetes Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition","has_exemption":false,"start_date":"2025-06-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Viking Therapeutics, Inc.","sponsor_slug":"viking-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104383","publication_url":"https://clinicaltrials.gov/study/NCT07104383","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 78-Week Efficacy and Safety Study of VK2735 Administered Subcutaneously for Weight Management in Participants With Type 2 Diabetes Who Are Obese, or Overweight","has_exemption":false,"start_date":"2025-06-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Viking Therapeutics, Inc.","sponsor_slug":"viking-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06725017","publication_url":"https://clinicaltrials.gov/study/NCT06725017","title":"A Phase 2, Multi-center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Live SK08 Powder (Bacteroides Fragilis) in Adult Patients with Active Mild to Moderate Ulcerative Colitis","has_exemption":false,"start_date":"2025-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Guangzhou Zhiyi Biotechnology Co., Ltd.","sponsor_slug":"guangzhou-zhiyi-biotechnology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06616649","publication_url":"https://clinicaltrials.gov/study/NCT06616649","title":"Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.","has_exemption":false,"start_date":"2025-07-14","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07108998","publication_url":"https://clinicaltrials.gov/study/NCT07108998","title":"A Phase 2 Study of Epcoritamab as a Consolidation Therapy for 2nd Generation BTKi +/- Obinutuzumab in CLL/SLL Patients or Variants of This.","has_exemption":false,"start_date":"2025-08-22","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Zulfa Omer","sponsor_slug":"zulfa-omer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06854224","publication_url":"https://clinicaltrials.gov/study/NCT06854224","title":"Orexin Antagonism to Target Mechanisms of Suicide Risk: A Proof-of-Concept Clinical Trial","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Marianne Goodman","sponsor_slug":"marianne-goodman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07121920","publication_url":"https://clinicaltrials.gov/study/NCT07121920","title":"A Prospective Study Evaluating Ex-vivo Confocal Imaging of Fluorescent Tagged Monoclonal Antibodies and Proteomic Profiles of Biopsied Tissue to Predict Therapeutic Response Among Children and Adolescents With Inflammatory Bowel Disease","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Cook Children's Health Care System","sponsor_slug":"cook-childrens-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07006714","publication_url":"https://clinicaltrials.gov/study/NCT07006714","title":"Preoperative Single High-Dose Vitamin D for Correcting Deficiency in Hip and Knee Arthroplasty Patients-A Prospective Study","has_exemption":false,"start_date":"2025-09-08","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07136779","publication_url":"https://clinicaltrials.gov/study/NCT07136779","title":"PHASE 1/2A OPEN-LABEL CLINICAL TRIAL EVALUATING VBC101, AN EGFR AND CMET TARGETED BI-SPECIFIC ANTIBODY DRUG CONJUGATE, IN PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES","has_exemption":false,"start_date":"2025-09-23","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"VelaVigo Bio Inc","sponsor_slug":"velavigo-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07037836","publication_url":"https://clinicaltrials.gov/study/NCT07037836","title":"Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia","has_exemption":false,"start_date":"2025-09-29","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Bastiaan Driehuys","sponsor_slug":"bastiaan-driehuys","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224997","publication_url":"https://clinicaltrials.gov/study/NCT07224997","title":"Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Civil de Guadalajara","sponsor_slug":"hospital-civil-de-guadalajara","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07410806","publication_url":"https://clinicaltrials.gov/study/NCT07410806","title":"HEALEY ALS Platform Trial - Regimen I NUZ-001","has_exemption":false,"start_date":"2026-02-16","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Merit E. Cudkowicz, MD","sponsor_slug":"merit-e-cudkowicz-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07639359","publication_url":"https://clinicaltrials.gov/study/NCT07639359","title":"Ketamine In Depression - Intensive Care Unit Trial (KID-ICU): A Phase II Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Ketamine Infusion for Depressive Symptoms in Intensive Care Unit Patients","has_exemption":false,"start_date":"2026-05-14","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Italiano de Buenos Aires","sponsor_slug":"hospital-italiano-de-buenos-aires","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07336238","publication_url":"https://clinicaltrials.gov/study/NCT07336238","title":"A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression","has_exemption":false,"start_date":"2026-05-19","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07664189","publication_url":"https://clinicaltrials.gov/study/NCT07664189","title":"Left Bundle Branch Pacing + Coronary Sinus Pacing Versus Left Bundle Branch Pacing Alone for Cardiac Resynchronization Therapy in Patients Eligible for CRT-P A Randomized Crossover Pilot Clinical Trial","has_exemption":false,"start_date":"2026-05-25","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Clinica Cardio VID","sponsor_slug":"clinica-cardio-vid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07337577","publication_url":"https://clinicaltrials.gov/study/NCT07337577","title":"Large Language Model-Generated Messages to Improve Guideline-Directed Medical Therapy in Heart Failure","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07659366","publication_url":"https://clinicaltrials.gov/study/NCT07659366","title":"HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia: A Prospective, Individually-Randomized, Triple-Blind, Sham-Controlled, Decentralized, Superiority Trial: A Prospective, Decentralized, Individually-randomized, Triple-blind Sham-controlled, Superiority Trial to Evaluate the Safety and Efficacy of HALO Clarity™ Device in Reducing Insomnia Severity.","has_exemption":false,"start_date":"2026-06-22","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Nexalin Technology","sponsor_slug":"nexalin-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07233200","publication_url":"https://clinicaltrials.gov/study/NCT07233200","title":"Serial Dermabrasion for Aesthetic Enhancement of Free Flap Skin Paddles and Donor Sites: A Prospective Split-Flap/Scar Controlled Study","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07444827","publication_url":"https://clinicaltrials.gov/study/NCT07444827","title":"Study of Targeted Injection of Nerves to the Knee-A Volunteer Trial Evaluating Nerve to Vastus Medialis","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07588399","publication_url":"https://clinicaltrials.gov/study/NCT07588399","title":"Randomized Pilot Study to Mechanistically Evaluate Automatic Flow Mode on Impella CP Device During Protected Complex Percutaneous Coronary Intervention","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"Rayyan Hemetsberger","sponsor_slug":"rayyan-hemetsberger","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07600697","publication_url":"https://clinicaltrials.gov/study/NCT07600697","title":"Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-07-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04143724","publication_url":"https://clinicaltrials.gov/study/NCT04143724","title":"A Phase 2a Study to Evaluate the Safety and Pharmacokinetics of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia","has_exemption":false,"start_date":"2019-11-07","completion_date":"2027-07-02","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05636176","publication_url":"https://clinicaltrials.gov/study/NCT05636176","title":"Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation","has_exemption":false,"start_date":"2023-05-08","completion_date":"2027-07-02","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07157787","publication_url":"https://clinicaltrials.gov/study/NCT07157787","title":"A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants With PMN (Primary Membranous Nephropathy) Who Are at a High Risk for Disease Progression","has_exemption":false,"start_date":"2025-09-19","completion_date":"2027-07-02","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06002906","publication_url":"https://clinicaltrials.gov/study/NCT06002906","title":"The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery","has_exemption":false,"start_date":"2023-01-25","completion_date":"2027-07-03","has_results":false,"results_due":false,"sponsor_name":"University Health Network, Toronto","sponsor_slug":"university-health-network-toronto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06211036","publication_url":"https://clinicaltrials.gov/study/NCT06211036","title":"A Phase 3, Open-label, Multicenter, Randomized Study of Tarlatamab in Combination With Durvalumab vs Durvalumab Alone in Subjects With Extensive-Stage Small-Cell Lung Cancer Following Platinum, Etoposide and Durvalumab (DeLLphi-305)","has_exemption":false,"start_date":"2024-06-05","completion_date":"2027-07-05","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630091","publication_url":"https://clinicaltrials.gov/study/NCT06630091","title":"A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study","has_exemption":false,"start_date":"2025-02-21","completion_date":"2027-07-05","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07099625","publication_url":"https://clinicaltrials.gov/study/NCT07099625","title":"Optimization of Adaptive Rowing Seating (OARS)","has_exemption":false,"start_date":"2026-07-06","completion_date":"2027-07-05","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05897320","publication_url":"https://clinicaltrials.gov/study/NCT05897320","title":"Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine","has_exemption":false,"start_date":"2023-06-08","completion_date":"2027-07-06","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03580083","publication_url":"https://clinicaltrials.gov/study/NCT03580083","title":"A Phase I/II Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Intracisternal RGX-111 Gene Therapy in Participants With Mucopolysaccharidosis Type I","has_exemption":false,"start_date":"2019-04-03","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"Regenxbio Inc.","sponsor_slug":"regenxbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07158164","publication_url":"https://clinicaltrials.gov/study/NCT07158164","title":"DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment","has_exemption":false,"start_date":"2025-08-27","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497880","publication_url":"https://clinicaltrials.gov/study/NCT07497880","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity","has_exemption":false,"start_date":"2026-04-06","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"Kailera","sponsor_slug":"kailera","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07610837","publication_url":"https://clinicaltrials.gov/study/NCT07610837","title":"A Phase IIa, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD2389 in Adult Participants With Steatotic Liver Disease and Advanced Fibrosis (BRAVO)","has_exemption":false,"start_date":"2026-05-07","completion_date":"2027-07-07","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05517304","publication_url":"https://clinicaltrials.gov/study/NCT05517304","title":"Transcutaneous Vagal Nerve Stimulation in Veterans With Posttraumatic Stress Disorder","has_exemption":false,"start_date":"2022-10-01","completion_date":"2027-07-08","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095128","publication_url":"https://clinicaltrials.gov/study/NCT06095128","title":"An Open-Label, Phase 4, Single-Arm, Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy With Tofacitinib in Adult Patients With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2024-06-12","completion_date":"2027-07-09","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06290141","publication_url":"https://clinicaltrials.gov/study/NCT06290141","title":"A Phase 3, Randomized, Double-blind, Study Evaluating Efficacy and Safety of Riliprubart Versus Intravenous Immunoglobulin (IVIg) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy","has_exemption":false,"start_date":"2024-08-21","completion_date":"2027-07-09","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06312176","publication_url":"https://clinicaltrials.gov/study/NCT06312176","title":"An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-04-14","completion_date":"2027-07-11","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03582774","publication_url":"https://clinicaltrials.gov/study/NCT03582774","title":"Phase III Randomized Multicenter Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]","has_exemption":false,"start_date":"2018-07-12","completion_date":"2027-07-12","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05441280","publication_url":"https://clinicaltrials.gov/study/NCT05441280","title":"Pimavanserin for Insomnia in Veterans With Post-traumatic Stress Disorder","has_exemption":false,"start_date":"2023-12-28","completion_date":"2027-07-12","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07639021","publication_url":"https://clinicaltrials.gov/study/NCT07639021","title":"Evaluation of Different Dose Escalation Regimens for NNC0662-0419 in Participants With Obesity","has_exemption":false,"start_date":"2026-06-09","completion_date":"2027-07-12","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06205706","publication_url":"https://clinicaltrials.gov/study/NCT06205706","title":"Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1910, a Monoclonal Antibody to Tumor Necrosis Factor Receptor 2 (TNFR2), as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-12-04","completion_date":"2027-07-14","has_results":false,"results_due":false,"sponsor_name":"BioInvent International AB","sponsor_slug":"bioinvent-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847867","publication_url":"https://clinicaltrials.gov/study/NCT06847867","title":"A Phase 2, Randomized, Open-label, Study of Momelotinib in Participants With Anemia Due to Low-risk Myelodysplastic Syndrome","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-07-14","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07593079","publication_url":"https://clinicaltrials.gov/study/NCT07593079","title":"Optimizing PSMA Imaging for Enhanced Detection of Residual and Metastatic Prostate Cancer in Low PSA Recurrence (OPERA) Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-07-14","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03516708","publication_url":"https://clinicaltrials.gov/study/NCT03516708","title":"Phase I/II Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer","has_exemption":false,"start_date":"2020-01-06","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05189457","publication_url":"https://clinicaltrials.gov/study/NCT05189457","title":"A Phase IIA Study of Sequential (\"First Strike, Second Strike\") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for High Risk Metastatic Castration Sensitive Prostate Cancer","has_exemption":false,"start_date":"2022-01-25","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05057494","publication_url":"https://clinicaltrials.gov/study/NCT05057494","title":"A Phase III Prospective, Multicenter, Randomized, Open-Label Trial of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","has_exemption":false,"start_date":"2022-09-12","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05892744","publication_url":"https://clinicaltrials.gov/study/NCT05892744","title":"Establishing Multimodal Brain Biomarkers Using Data-driven Analytics for Treatment Selection in Depression","has_exemption":false,"start_date":"2023-09-30","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06940674","publication_url":"https://clinicaltrials.gov/study/NCT06940674","title":"Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS)","has_exemption":false,"start_date":"2025-06-13","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07325292","publication_url":"https://clinicaltrials.gov/study/NCT07325292","title":"A Randomized, Phase 3, Open-label Study to Investigate Pharmacokinetics, Safety, and Efficacy of Subcutaneous Compared to Intravenous Frexalimab in Adult Participants With Multiple Sclerosis","has_exemption":false,"start_date":"2026-01-14","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07573059","publication_url":"https://clinicaltrials.gov/study/NCT07573059","title":"A Multicenter, Prospective Study Assessing the Safety of Loargys Arginine Test System for Determining Arginine in Loargys-treated Patients","has_exemption":false,"start_date":"2026-04-17","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Immedica Pharma US Inc","sponsor_slug":"immedica-pharma-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07322289","publication_url":"https://clinicaltrials.gov/study/NCT07322289","title":"Evaluating the Use of Antibiotic-Coated Braided Sutures in Debridement, Antibiotic, and Implant Retention (DAIR) Procedures","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07588672","publication_url":"https://clinicaltrials.gov/study/NCT07588672","title":"Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis","has_exemption":false,"start_date":"2026-07-15","completion_date":"2027-07-15","has_results":false,"results_due":false,"sponsor_name":"Polyrizon Ltd.","sponsor_slug":"polyrizon-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03460067","publication_url":"https://clinicaltrials.gov/study/NCT03460067","title":"Selective Use of Observation After Lumpectomy and Sentinel Lymph Node Biopsy in Her-2 Positive Patients With Pathologic Complete Response to Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2018-02-23","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05347212","publication_url":"https://clinicaltrials.gov/study/NCT05347212","title":"Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla","has_exemption":false,"start_date":"2022-09-22","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05664737","publication_url":"https://clinicaltrials.gov/study/NCT05664737","title":"A Phase 2, Study for the Treatment of Anemia With Alpha (α)-Thalassemia to Determine the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) in Adults and Evaluate the Safety and Pharmacokinetics in Adolescents","has_exemption":false,"start_date":"2022-12-09","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06005493","publication_url":"https://clinicaltrials.gov/study/NCT06005493","title":"A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5863, a T Cell-engaging Bispecific Antibody That Targets Claudin 18.2 (CLDN18.2) and CD3 in Adult Participants With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-07-11","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05798923","publication_url":"https://clinicaltrials.gov/study/NCT05798923","title":"A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAM-001 in Adults With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","has_exemption":false,"start_date":"2023-08-30","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"OrphAI Therapeutics","sponsor_slug":"orphai-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07047118","publication_url":"https://clinicaltrials.gov/study/NCT07047118","title":"A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Lutetium (177Lu) Vipivotide Tetraxetan in Adult Male Patients With PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2025-07-03","completion_date":"2027-07-16","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06806592","publication_url":"https://clinicaltrials.gov/study/NCT06806592","title":"A Double Blind, Randomised, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nerandomilast Over at Least 26 Weeks in Patients With Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases (SARD-ILD)","has_exemption":false,"start_date":"2025-09-13","completion_date":"2027-07-17","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02396459","publication_url":"https://clinicaltrials.gov/study/NCT02396459","title":"Tiratricol Treatment of Children With Monocarboxylate Transporter 8 Deficiency: Triac Trial II","has_exemption":false,"start_date":"2020-12-07","completion_date":"2027-07-18","has_results":false,"results_due":false,"sponsor_name":"Rare Thyroid Therapeutics International AB","sponsor_slug":"rare-thyroid-therapeutics-international-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07187778","publication_url":"https://clinicaltrials.gov/study/NCT07187778","title":"Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-07-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07482813","publication_url":"https://clinicaltrials.gov/study/NCT07482813","title":"An Open Label Extension, Multi-Center Study to Evaluate the Safety of SD 101 Cream in Subjects With Epidermolysis Bullosa","has_exemption":false,"start_date":"2026-07-15","completion_date":"2027-07-19","has_results":false,"results_due":false,"sponsor_name":"Paradigm Therapeutics","sponsor_slug":"paradigm-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03708900","publication_url":"https://clinicaltrials.gov/study/NCT03708900","title":"A Phase II, Multicenter, Open-label, Non-comparative Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Osilodrostat in Children and Adolescent Patients With Cushing's Syndrome","has_exemption":false,"start_date":"2021-04-28","completion_date":"2027-07-21","has_results":false,"results_due":false,"sponsor_name":"RECORDATI GROUP","sponsor_slug":"recordati-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05555485","publication_url":"https://clinicaltrials.gov/study/NCT05555485","title":"Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain","has_exemption":false,"start_date":"2023-05-24","completion_date":"2027-07-21","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05745298","publication_url":"https://clinicaltrials.gov/study/NCT05745298","title":"The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury","has_exemption":false,"start_date":"2023-07-21","completion_date":"2027-07-21","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06637631","publication_url":"https://clinicaltrials.gov/study/NCT06637631","title":"A Phase 2, Multinational, Multicenter, Randomized, Doubleblind, Placebocontrolled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR441566 in Adults With Moderate to Severe Crohn's Disease.","has_exemption":false,"start_date":"2024-12-10","completion_date":"2027-07-21","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531786","publication_url":"https://clinicaltrials.gov/study/NCT05531786","title":"Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","has_exemption":false,"start_date":"2023-03-06","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06472206","publication_url":"https://clinicaltrials.gov/study/NCT06472206","title":"Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)","has_exemption":false,"start_date":"2024-09-23","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044297","publication_url":"https://clinicaltrials.gov/study/NCT07044297","title":"A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis","has_exemption":false,"start_date":"2025-07-31","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07062965","publication_url":"https://clinicaltrials.gov/study/NCT07062965","title":"An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator's Choice of Therapy in Adult Participants With Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-based Therapy","has_exemption":false,"start_date":"2025-08-05","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161037","publication_url":"https://clinicaltrials.gov/study/NCT07161037","title":"A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VX-407 in Subjects With Autosomal Dominant Polycystic Kidney Disease Who Have a Subset of PKD1 Gene Variants","has_exemption":false,"start_date":"2025-11-19","completion_date":"2027-07-22","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06975865","publication_url":"https://clinicaltrials.gov/study/NCT06975865","title":"A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Flexible-adaptive, Group Sequential Study to Evaluate the Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease","has_exemption":false,"start_date":"2025-08-12","completion_date":"2027-07-23","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044310","publication_url":"https://clinicaltrials.gov/study/NCT07044310","title":"Phase 2 Trial of 5-Strain Probiotic Formulation in Hormone Receptor-Positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss","has_exemption":false,"start_date":"2025-07-25","completion_date":"2027-07-25","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07202546","publication_url":"https://clinicaltrials.gov/study/NCT07202546","title":"A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of Oral VH4524184 Coadministered With Emtricitabine and Tenofovir Alafenamide in Treatment Naive Viremic Persons With HIV-1 (INNOVATE Study)","has_exemption":false,"start_date":"2026-02-11","completion_date":"2027-07-26","has_results":false,"results_due":false,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00840047","publication_url":"https://clinicaltrials.gov/study/NCT00840047","title":"Methionine PET/CT Studies In Patients With Cancer","has_exemption":false,"start_date":"2009-07-20","completion_date":"2027-07-27","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05562947","publication_url":"https://clinicaltrials.gov/study/NCT05562947","title":"A Phase III, Multicenter, Randomized, Visual Assessor-masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Chinese Patients With Neovascular Age-related Macular Degeneration","has_exemption":false,"start_date":"2024-06-17","completion_date":"2027-07-27","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05895786","publication_url":"https://clinicaltrials.gov/study/NCT05895786","title":"A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS)","has_exemption":false,"start_date":"2023-05-20","completion_date":"2027-07-28","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06103864","publication_url":"https://clinicaltrials.gov/study/NCT06103864","title":"A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)","has_exemption":false,"start_date":"2023-11-23","completion_date":"2027-07-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06867094","publication_url":"https://clinicaltrials.gov/study/NCT06867094","title":"A Phase 2, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR441566 in Adults With Moderate-to-severe Ulcerative Colitis","has_exemption":false,"start_date":"2025-03-28","completion_date":"2027-07-29","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03040973","publication_url":"https://clinicaltrials.gov/study/NCT03040973","title":"An Open-label, Multi-center, Global, Rollover Study for Patients Who Have Previously Been Treated With Capmatinib (INC280) as Monotherapy or in Combination in a Novartis Sponsored Trial.","has_exemption":false,"start_date":"2017-08-23","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03535298","publication_url":"https://clinicaltrials.gov/study/NCT03535298","title":"Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis","has_exemption":false,"start_date":"2019-01-03","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04524871","publication_url":"https://clinicaltrials.gov/study/NCT04524871","title":"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)","has_exemption":false,"start_date":"2020-11-01","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280377","publication_url":"https://clinicaltrials.gov/study/NCT07280377","title":"A Phase 1 / 2 Multiple-indication Biomarker, Safety, and Efficacy Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab","has_exemption":false,"start_date":"2021-10-27","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Oncolytics Biotech","sponsor_slug":"oncolytics-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090891","publication_url":"https://clinicaltrials.gov/study/NCT05090891","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva","has_exemption":false,"start_date":"2022-05-05","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05455320","publication_url":"https://clinicaltrials.gov/study/NCT05455320","title":"A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd), in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 1 Prior Line of Therapy","has_exemption":false,"start_date":"2022-10-13","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672524","publication_url":"https://clinicaltrials.gov/study/NCT05672524","title":"A Phase II Study of Induction Tucatinib and Trastuzumab With Total Neoadjuvant Therapy for Locally Advanced HER2-amplified Rectal Adenocarcinoma","has_exemption":false,"start_date":"2022-12-30","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05282550","publication_url":"https://clinicaltrials.gov/study/NCT05282550","title":"RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone (REST)","has_exemption":false,"start_date":"2023-02-02","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05794906","publication_url":"https://clinicaltrials.gov/study/NCT05794906","title":"A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide Plus Androgen Deprivation Therapy (ADT) Compared With Placebo Plus ADT in Patients With High-risk Biochemical Recurrence (BCR) of Prostate Cancer","has_exemption":false,"start_date":"2023-04-03","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05507541","publication_url":"https://clinicaltrials.gov/study/NCT05507541","title":"Phase 2 Study With Safety run-in of PD-1 Inhibitor and IgG4 SIRPα-Fc Fusion Protein (TTI-622) in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2023-04-19","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05918640","publication_url":"https://clinicaltrials.gov/study/NCT05918640","title":"Lurbinectedin in FET-Fusion Tumors (LIFFT)","has_exemption":false,"start_date":"2023-07-27","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06072183","publication_url":"https://clinicaltrials.gov/study/NCT06072183","title":"A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBO-CONTROLLED MULTI-CENTER STUDY WITH A DOUBLE-BLIND 52-WEEK EXTENSION PERIOD WITH RANDOMIZED DOSE UP/DOSE DOWN TITRATION INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT PARTICIPANTS WITH NONSEGMENTAL VITILIGO","has_exemption":false,"start_date":"2023-11-08","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05904028","publication_url":"https://clinicaltrials.gov/study/NCT05904028","title":"Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD","has_exemption":false,"start_date":"2023-11-09","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06079879","publication_url":"https://clinicaltrials.gov/study/NCT06079879","title":"A Phase 3, Randomized, Open-label, Active-Comparator-Controlled Clinical Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543/IMG-7289) Versus Best Available Therapy (BAT) in Participants With Essential Thrombocythemia Who Have an Inadequate Response to or Are Intolerant of Hydroxyurea","has_exemption":false,"start_date":"2023-12-31","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06096779","publication_url":"https://clinicaltrials.gov/study/NCT06096779","title":"A Phase II, Open-label, Multi-cohort, Multicenter Study in Patients With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis","has_exemption":false,"start_date":"2024-07-15","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06448754","publication_url":"https://clinicaltrials.gov/study/NCT06448754","title":"A Phase II, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Volrustomig Priming Regimens in Combination With Other Anticancer Agents in Participants With Solid Tumors (eVOLVE-01)","has_exemption":false,"start_date":"2024-08-27","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06470048","publication_url":"https://clinicaltrials.gov/study/NCT06470048","title":"A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis","has_exemption":false,"start_date":"2024-10-09","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06635824","publication_url":"https://clinicaltrials.gov/study/NCT06635824","title":"A Prospective, Open-Label, Randomized, Phase 3 Trial of Acasunlimab (GEN1046) in Combination With Pembrolizumab Versus Docetaxel in Subjects With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer After Treatment With a PD-1/PD-L1 Inhibitor and Platinum-Containing Chemotherapy (ABBIL1TY NSCLC-06)","has_exemption":false,"start_date":"2024-11-25","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06636656","publication_url":"https://clinicaltrials.gov/study/NCT06636656","title":"Phase IIa, Sequential Cohort, Open-label, Multi-center Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Induction and Subcutaneous Maintenance Treatment With BI 3032950 in Patients With Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2024-12-11","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06132685","publication_url":"https://clinicaltrials.gov/study/NCT06132685","title":"Post-Operative Dosing of Steroids Post Craniotomy for Brain Tumor (PODS)","has_exemption":false,"start_date":"2025-01-09","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06466161","publication_url":"https://clinicaltrials.gov/study/NCT06466161","title":"Evaluation of the Agreement Between Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients","has_exemption":false,"start_date":"2025-04-29","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06918808","publication_url":"https://clinicaltrials.gov/study/NCT06918808","title":"A Phase 2a Study of Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product (DB-3Q) in Patients With Perianal Fistulizing Crohn's Disease","has_exemption":false,"start_date":"2025-05-19","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Direct Biologics, LLC","sponsor_slug":"direct-biologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06772233","publication_url":"https://clinicaltrials.gov/study/NCT06772233","title":"A Phase II, Open-label, Multicenter, Randomized Controlled Clinical Trial Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment.","has_exemption":false,"start_date":"2025-07-30","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Peking University","sponsor_slug":"peking-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07010016","publication_url":"https://clinicaltrials.gov/study/NCT07010016","title":"Early Feasibility Study of Focused Ultrasound (FUS) Neuromodulation in Patients With Opioid Use Disorder and/or Other Substance Use Disorders","has_exemption":false,"start_date":"2025-08-07","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"Manish Ranjan","sponsor_slug":"manish-ranjan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07608588","publication_url":"https://clinicaltrials.gov/study/NCT07608588","title":"Recovery From Post-Stroke Aphasia With rTMS Targeting the Anterior Temporal Lobe: Interhemispheric Activation Changes and Lesion-Connectome-Based Predictive Outcomes","has_exemption":false,"start_date":"2026-05-15","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"University of South Carolina","sponsor_slug":"university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06406465","publication_url":"https://clinicaltrials.gov/study/NCT06406465","title":"A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity","has_exemption":false,"start_date":"2026-06-29","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07619131","publication_url":"https://clinicaltrials.gov/study/NCT07619131","title":"A Phase III Randomised, Double-Blind, Factorial Design Study to Assess the Effect of Fixed Dose Combination Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on Low-Density Lipoprotein Cholesterol in Lipid-Lowering Treatment-Naïve Patients","has_exemption":false,"start_date":"2026-08-17","completion_date":"2027-07-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00909909","publication_url":"https://clinicaltrials.gov/study/NCT00909909","title":"Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in Women With Breast Cancer: A Phase II Trial","has_exemption":false,"start_date":"2009-05-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01530373","publication_url":"https://clinicaltrials.gov/study/NCT01530373","title":"A Phase II Randomized Study of Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients Receiving Adjuvant Hormonal Therapy","has_exemption":false,"start_date":"2012-02-29","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02225600","publication_url":"https://clinicaltrials.gov/study/NCT02225600","title":"The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults: A Pilot Behavioral Study","has_exemption":false,"start_date":"2014-08-26","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02262832","publication_url":"https://clinicaltrials.gov/study/NCT02262832","title":"Compassionate Use of Metreleptin in Previously-Treated Patients With Generalized Lipodystrophy","has_exemption":false,"start_date":"2014-10-09","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02262806","publication_url":"https://clinicaltrials.gov/study/NCT02262806","title":"Compassionate Use of Metreleptin in Previously-Treated Patients With Partial Lipodystrophy","has_exemption":false,"start_date":"2014-10-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02502162","publication_url":"https://clinicaltrials.gov/study/NCT02502162","title":"Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome","has_exemption":false,"start_date":"2015-06-30","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02479698","publication_url":"https://clinicaltrials.gov/study/NCT02479698","title":"Phase II Study Assessing the Effect of BK Specific CTL Lines Generated by Ex Vivo Expansion in Patients With BK Virus Infection and JC Virus Infection","has_exemption":false,"start_date":"2015-07-23","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02698254","publication_url":"https://clinicaltrials.gov/study/NCT02698254","title":"Pilot Trial of Dose-Volume Constraints for Reirradiation of Recurrent Brain Tumors","has_exemption":false,"start_date":"2016-07-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02846987","publication_url":"https://clinicaltrials.gov/study/NCT02846987","title":"Phase 2 Study of Abemaciclib (LY2835219) in Dedifferentiated Liposarcoma","has_exemption":false,"start_date":"2016-07-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03006068","publication_url":"https://clinicaltrials.gov/study/NCT03006068","title":"A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects With Ulcerative Colitis","has_exemption":false,"start_date":"2017-01-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03067051","publication_url":"https://clinicaltrials.gov/study/NCT03067051","title":"Open-label Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System (Interstitial Multiple Diode Lasers and IDOSE® Software) and Verteporfin for Injection (VFI) for the Treatment of Recurrent Prostate Cancer","has_exemption":false,"start_date":"2017-03-21","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"SpectraCure AB","sponsor_slug":"spectracure-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02845323","publication_url":"https://clinicaltrials.gov/study/NCT02845323","title":"Randomized Phase II Study of Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder","has_exemption":false,"start_date":"2017-05-16","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03181100","publication_url":"https://clinicaltrials.gov/study/NCT03181100","title":"Atezolizumab Combinations With Chemotherapy for Anaplastic and Poorly Differentiated Thyroid Carcinomas","has_exemption":false,"start_date":"2017-07-27","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03278782","publication_url":"https://clinicaltrials.gov/study/NCT03278782","title":"A Phase I/II Study of Pembrolizumab (MK-3475) in Combination With Romidepsin in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma","has_exemption":false,"start_date":"2017-11-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03467516","publication_url":"https://clinicaltrials.gov/study/NCT03467516","title":"A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Uveal Melanoma","has_exemption":false,"start_date":"2018-05-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Udai Kammula","sponsor_slug":"udai-kammula","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03541902","publication_url":"https://clinicaltrials.gov/study/NCT03541902","title":"Cabosun Ii: Cabozantinib Versus Sunitinib for Metastatic Variant Histology Renal Cell Carcinoma","has_exemption":false,"start_date":"2018-05-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03556332","publication_url":"https://clinicaltrials.gov/study/NCT03556332","title":"Phase 2 Trial of Intensive Chemo-immunotherapy With Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Relapsed/Refractory Myeloma in the Context of Salvage Autologous Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2018-07-02","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587844","publication_url":"https://clinicaltrials.gov/study/NCT03587844","title":"Optimizing Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome, and Lymphomatoid Papulosis","has_exemption":false,"start_date":"2018-07-03","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03536767","publication_url":"https://clinicaltrials.gov/study/NCT03536767","title":"An Open-Label Extension and Safety Monitoring Study of Patients with Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201","has_exemption":false,"start_date":"2018-08-08","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Eidos Therapeutics, a BridgeBio company","sponsor_slug":"eidos-therapeutics-a-bridgebio-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03623958","publication_url":"https://clinicaltrials.gov/study/NCT03623958","title":"Image Guided VATS Resection vs. VATS Resection of Lung Lesions","has_exemption":false,"start_date":"2018-09-11","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06443359","publication_url":"https://clinicaltrials.gov/study/NCT06443359","title":"Hypofractionated Regional Nodal Irradiation in Breast Cancer","has_exemption":false,"start_date":"2018-11-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03546582","publication_url":"https://clinicaltrials.gov/study/NCT03546582","title":"KEYSTROKE: A Randomized Phase II Study of Pembrolizumab (KEYTRUDA®) Plus Stereotactic Re-irradiation Versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma","has_exemption":false,"start_date":"2018-11-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"RTOG Foundation, Inc.","sponsor_slug":"rtog-foundation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03521830","publication_url":"https://clinicaltrials.gov/study/NCT03521830","title":"Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma","has_exemption":false,"start_date":"2018-11-27","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03977233","publication_url":"https://clinicaltrials.gov/study/NCT03977233","title":"Impact of Tumor and Stromal Subtypes on Efficacy of Neoadjuvant FOLFIRINOX in Subjects With Non-Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2019-06-12","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04065776","publication_url":"https://clinicaltrials.gov/study/NCT04065776","title":"A Phase II Study of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma","has_exemption":false,"start_date":"2019-08-28","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04151082","publication_url":"https://clinicaltrials.gov/study/NCT04151082","title":"Stop LCNP: High Dose Steroid Therapy for Late Radiation-Associated Lower Cranial Neuropathy: A Phase I/II Dose Finding Trial and Data Registry","has_exemption":false,"start_date":"2019-10-16","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04073563","publication_url":"https://clinicaltrials.gov/study/NCT04073563","title":"Prospective, Randomized, Controlled, Blinded Pivotal Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse™ Bone Graft With an Intervertebral Body Fusion Device and Posterior Supplemental Fixation For The Treatment Of Symptomatic Degenerative Disease Of The Lumbosacral Spine","has_exemption":false,"start_date":"2019-12-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Spinal and Biologics","sponsor_slug":"medtronic-spinal-and-biologics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04022239","publication_url":"https://clinicaltrials.gov/study/NCT04022239","title":"Post-Transplant Bendamustine (PT-BEN) for GVHD Prophylaxis","has_exemption":false,"start_date":"2020-03-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01187368","publication_url":"https://clinicaltrials.gov/study/NCT01187368","title":"Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System: the COMPETENCE Trial","has_exemption":false,"start_date":"2020-03-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Evaheart, Inc.","sponsor_slug":"evaheart-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04297683","publication_url":"https://clinicaltrials.gov/study/NCT04297683","title":"HEALEY ALS Platform Trial","has_exemption":false,"start_date":"2020-06-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Merit E. Cudkowicz, MD","sponsor_slug":"merit-e-cudkowicz-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02314988","publication_url":"https://clinicaltrials.gov/study/NCT02314988","title":"Topical Application of Tranexamic Acid (CYKLOKAPRON®) to Reduce Blood Loss During Spine Surgery","has_exemption":false,"start_date":"2020-06-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04333576","publication_url":"https://clinicaltrials.gov/study/NCT04333576","title":"A Phase 3b Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Combined Oral Contraceptives in Premenopausal Women With Documented Endometriosis and Associated Moderate to Severe Pain","has_exemption":false,"start_date":"2020-08-10","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04401748","publication_url":"https://clinicaltrials.gov/study/NCT04401748","title":"A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Azacitidine in Patients Newly Diagnosed With Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)","has_exemption":false,"start_date":"2020-09-10","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04697784","publication_url":"https://clinicaltrials.gov/study/NCT04697784","title":"Post-Approval Study of the TREO Abdominal Stent-Graft System (P190015) in Patients With Infrarenal Abdominal Aortic and Aorto-iliac Aneurysms","has_exemption":false,"start_date":"2021-01-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Bolton Medical","sponsor_slug":"bolton-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04760899","publication_url":"https://clinicaltrials.gov/study/NCT04760899","title":"Bilateral Cerebellar Transcranial Direct Current Stimulation (tDCS) for the Treatment of Sports-Related Post-Concussion Syndrome (SRPCS)","has_exemption":false,"start_date":"2021-03-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04639050","publication_url":"https://clinicaltrials.gov/study/NCT04639050","title":"A Phase Ib/IIa, Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Patients With Prodromal or Mild to Moderate Alzheimer's Disease","has_exemption":false,"start_date":"2021-03-15","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04586959","publication_url":"https://clinicaltrials.gov/study/NCT04586959","title":"Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer","has_exemption":false,"start_date":"2021-05-21","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Anthony Costales, MD","sponsor_slug":"anthony-costales-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04573231","publication_url":"https://clinicaltrials.gov/study/NCT04573231","title":"Evaluation of Prostate Specific Membrane Antigen (PSMA) in HER2-negative, Androgen Receptor (AR)-Positive Metastatic Breast Cancer With 18F-DCFPyL PSMA-based PET/CT","has_exemption":false,"start_date":"2021-05-24","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04841148","publication_url":"https://clinicaltrials.gov/study/NCT04841148","title":"A Phase II Trial of Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)","has_exemption":false,"start_date":"2021-06-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03701581","publication_url":"https://clinicaltrials.gov/study/NCT03701581","title":"4-aminopyridine Treatment for Nerve Injury Resulting From Radical Retro-Pubic Prostatectomy","has_exemption":false,"start_date":"2021-06-05","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"John Elfar","sponsor_slug":"john-elfar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05024695","publication_url":"https://clinicaltrials.gov/study/NCT05024695","title":"A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the MINIject CS627 Implant in Subjects With Open Angle Glaucoma","has_exemption":false,"start_date":"2021-08-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"iSTAR Medical","sponsor_slug":"istar-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03776162","publication_url":"https://clinicaltrials.gov/study/NCT03776162","title":"BEAR - MOON: A Two Arm Non-Inferiority Randomized Clinical Trial Comparing ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction","has_exemption":false,"start_date":"2021-08-30","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03921060","publication_url":"https://clinicaltrials.gov/study/NCT03921060","title":"Markers of Osteoporosis in Cystic Fibrosis","has_exemption":false,"start_date":"2021-09-02","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04976335","publication_url":"https://clinicaltrials.gov/study/NCT04976335","title":"Quantitative and Clinical Assessment of Flexor Tendon Gliding Following Application of a Bioresorbable Hydrogel: A Prospective, Randomized Study in Patients Undergoing Distal Radius Fracture Repair.","has_exemption":false,"start_date":"2021-09-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04960618","publication_url":"https://clinicaltrials.gov/study/NCT04960618","title":"Pembrolizumab in Combination With Gemcitabine for Previously Treated Mycosis Fungoides and Sézary Syndrome: Efficacy and Characterization of Immune Response","has_exemption":false,"start_date":"2021-10-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05003310","publication_url":"https://clinicaltrials.gov/study/NCT05003310","title":"Multipart Exploratory Study to Evaluate Splenic Nerve Stimulation in Patients With Rheumatoid Arthritis","has_exemption":false,"start_date":"2021-10-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Galvani Bioelectronics","sponsor_slug":"galvani-bioelectronics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05102019","publication_url":"https://clinicaltrials.gov/study/NCT05102019","title":"Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II","has_exemption":false,"start_date":"2022-01-04","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Shockwave Medical, Inc.","sponsor_slug":"shockwave-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05011188","publication_url":"https://clinicaltrials.gov/study/NCT05011188","title":"A Phase 1b/2 Study of FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2022-01-19","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Rahul Aggarwal","sponsor_slug":"rahul-aggarwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05207670","publication_url":"https://clinicaltrials.gov/study/NCT05207670","title":"An Open-Label, Multicenter, Phase II Trial Evaluating the Safety, Efficacy, and Pharmacokinetics of Subcutaneous Mosunetuzumab Monotherapy in Patients With Select B-Cell Malignancies","has_exemption":false,"start_date":"2022-02-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05028062","publication_url":"https://clinicaltrials.gov/study/NCT05028062","title":"Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation","has_exemption":false,"start_date":"2022-03-07","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04644211","publication_url":"https://clinicaltrials.gov/study/NCT04644211","title":"A Phase 2 Study Of Ruxolitinib In Low-Risk Essential Thrombocythemia And Polycythemia Vera With Significant Symptom Burden","has_exemption":false,"start_date":"2022-03-21","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05401929","publication_url":"https://clinicaltrials.gov/study/NCT05401929","title":"Imaging the Effects of Intermittent Thetaburst Stimulation on Cannabis Self-Administration in Heavy Cannabis Users","has_exemption":false,"start_date":"2022-06-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05301101","publication_url":"https://clinicaltrials.gov/study/NCT05301101","title":"High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis (REDIRICT)","has_exemption":false,"start_date":"2022-06-13","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05209438","publication_url":"https://clinicaltrials.gov/study/NCT05209438","title":"Cereset Research for Caregivers: A Randomized, Controlled Trial","has_exemption":false,"start_date":"2022-06-16","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05172960","publication_url":"https://clinicaltrials.gov/study/NCT05172960","title":"Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve","has_exemption":false,"start_date":"2022-06-20","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05460533","publication_url":"https://clinicaltrials.gov/study/NCT05460533","title":"Phase II Open Label Multicenter Study of Early REinFusion of Tisagenlecleucel to Promote DUrable B-CEll ApLasia in Pediatric and Young Adult Patients With Relapsed/Refractory CD19-Positive B-Cell Acute Lymphoblastic Leukemia (REFUEL)","has_exemption":false,"start_date":"2022-07-12","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05434598","publication_url":"https://clinicaltrials.gov/study/NCT05434598","title":"A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS","has_exemption":false,"start_date":"2022-07-27","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05440760","publication_url":"https://clinicaltrials.gov/study/NCT05440760","title":"Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy","has_exemption":false,"start_date":"2022-08-08","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05600738","publication_url":"https://clinicaltrials.gov/study/NCT05600738","title":"Network Effects of Therapeutic Deep Brain Stimulation","has_exemption":false,"start_date":"2022-08-26","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05053867","publication_url":"https://clinicaltrials.gov/study/NCT05053867","title":"A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients","has_exemption":false,"start_date":"2022-10-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05460793","publication_url":"https://clinicaltrials.gov/study/NCT05460793","title":"Dutch ICH Surgery Trial; Minimally Invasive Endoscopy-guided Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage","has_exemption":false,"start_date":"2022-11-03","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Radboud University Medical Center","sponsor_slug":"radboud-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05215327","publication_url":"https://clinicaltrials.gov/study/NCT05215327","title":"Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients","has_exemption":false,"start_date":"2022-11-08","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05425459","publication_url":"https://clinicaltrials.gov/study/NCT05425459","title":"Re-Evaluation of the Corvia Atrial Shunt Device in a Precision Medicine Trial to Determine Efficacy in Mildly Reduced or Preserved Ejection Fraction (EF) Heart Failure (Protocol #2201)","has_exemption":false,"start_date":"2022-11-17","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Corvia Medical","sponsor_slug":"corvia-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05579366","publication_url":"https://clinicaltrials.gov/study/NCT05579366","title":"Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-12-07","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05370651","publication_url":"https://clinicaltrials.gov/study/NCT05370651","title":"A Single-Blind, Randomized Study of the BTL Emsella Chair Versus Sham for the Treatment of Male Sexual Dysfunction","has_exemption":false,"start_date":"2022-12-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05292339","publication_url":"https://clinicaltrials.gov/study/NCT05292339","title":"Single Blind RCT to Evaluate the Effect of Ketorolac in Upper Extremity Tendinopathy and Arthropathy","has_exemption":false,"start_date":"2023-01-31","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05587751","publication_url":"https://clinicaltrials.gov/study/NCT05587751","title":"Evaluating the Impact of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse (TGD) Patients","has_exemption":false,"start_date":"2023-02-01","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04711109","publication_url":"https://clinicaltrials.gov/study/NCT04711109","title":"BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation","has_exemption":false,"start_date":"2023-02-14","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05735080","publication_url":"https://clinicaltrials.gov/study/NCT05735080","title":"A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of INX-315 in Patients With Advanced Cancer","has_exemption":false,"start_date":"2023-03-28","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Incyclix Bio","sponsor_slug":"incyclix-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05809531","publication_url":"https://clinicaltrials.gov/study/NCT05809531","title":"An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis","has_exemption":false,"start_date":"2023-05-29","completion_date":"2027-07-31","has_results":false,"results_due":false,"sponsor_name":"Apellis Pharmaceuticals, Inc.","sponsor_slug":"apellis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null}]}